Factors such as the increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, and the growing collaboration between industries and academic institutes are the key drivers of the research antibodies market.
The Research Antibodies Market is
expected to reach USD 12.60 Billion by 2022 from an estimated USD 9.33 Billion
in 2017, at a CAGR of 6.2% during the forecast period.
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793
Market Segmentation:-
On the basis of product, the reagents segment accounted for the
largest share of the global research antibodies market (including reagents), in
2016. This can be attributed to the fact that a large number of reagents are
used in various routine assays and techniques.
Based on technology, the western blotting segment accounted for
the largest share of the Research Reagents Market. Its ability to quantify as
little as 0.1 nanograms of protein in a sample with high specificity makes it
an indispensable tool in proteomic research; this is the key factor driving
market growth.
Based on application, the proteomics segment accounted for the
largest share of the Research Reagents Market. The large share of this segment
is attributed to the deployment of proteomic-based approaches in biomarker
detection and cancer profiling, increasing R&D expenditure, and
availability of funds from various organizations.
Based on end user, the pharmaceutical & biotechnological companies
segment accounted for the largest share of the Research Antibodies and Reagents
Market owing to the high uptake of research-specific antibodies in the drug
discovery and development process, along with the increasing use of these
research tools in the ever-developing proteomics research sector.
Key Market Opportunities: -
1 High Growth Opportunities in
Emerging Markets
2 Increasing Demand for Personalized
Medicine and Protein Therapeutics
3 Growths in Stem Cell and
Neurobiology Research
4 Increasing Focus on Biomarker
Discovery
Regional Analysis:-
North America accounted for the largest share of the Research
Antibodies and Reagents Market in 2016, followed by Europe. This regional
segment shows significant market growth opportunities owing to the increasing
research activities in the fields of proteomics and genomics, favorable
government funding initiatives, and the growing focus of stakeholders on
research projects.
Speak
To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=94212793
Top
Key Players:-
The major players in the research antibodies market (including
reagents) are Thermo Fisher Scientific, Inc. (U.S.), Merck Group (Germany),
Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories,
Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc.
(U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.),
GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend,
Inc. (U.S.).
No comments:
Post a Comment